DIIP Monthly Update – May 2018
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of May 2018.
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of May 2018.
South Centre Statement at the Meeting of Ministers of Health of the Member States of the Non-Aligned Movement
The South Centre reiterates its commitment to support the Non-Aligned countries so that there is close and effective cooperation among developing countries to strengthen a global health agenda. WHO was created as an international public agency in the service of global health. Recovering and reinforcing this role should be the work of all.
The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.
(Covering period: January – March 2018)
Outcomes of the 142nd session of the WHO Executive Board
The 142nd session of the WHO Executive Board discussed several critical public health issues including a recommendation to the WHA to approve the General Program of Work (GPW), the adoption of important decisions relating to access to medicines and research and development and a draft resolution on the preparation of the UN High Level Meeting on Tuberculosis.
The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.
(Covering period: July – December 2017)
Resistance to Antibiotics: The Good, the Bad and the Ugly
Action Needed to Avoid the End of Modern Medicine
Action Needed to Avoid the End of Modern Medicine
By Martin Khor
As global health leaders warn that antibiotic resistance is leading to the end of modern medicine, the World Health Organization (WHO) issues guidelines to prohibit or restrict using antibiotics to feed animals reared for their meat. Urgent coordinated actions are needed to avoid the end of modern medicine. The author Martin Khor is the Executive Director of the South Centre. This article was also published by Inter Press Service (IPS) (more…)
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of November 2017.
The International Debate on Generic Medicines of Biological Origin
The debate on generic medicines is not new. What makes it different today is that attacks levelled against biological products are couched in ever more “technical” and abstruse language that confuses even the World Health Organization (WHO).
WHO Advice: Stop using antibiotics in healthy animals to prevent the spread of antibiotic resistance
The Value Added of the United Nations General Assembly High–Level Political Declaration on Antimicrobial Resistance
In September 2016, the United Nations General Assembly (UNGA) in New York held a dedicated meeting to muster strong political commitment for an effective global response to the problem of antimicrobial resistance (AMR). As a result, a High-Level Political Declaration on Antimicrobial Resistance was adopted.